Who is the CEO of Drtech?

According to the DART company overview, Drtech's representative director is 안성현 (name as registered in Korean). The company was founded on 2015-02-03.

Where is Drtech listed?

Drtech trades on the Korea Exchange KOSDAQ market under the ticker 214680. Its fiscal year ends in December.

Does Drtech pay a dividend?

Drtech did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as Drtech?

Under the Korean Standard Industrial Classification recorded on DART, Drtech is grouped with 72 other listed companies in medical devices. The most covered in Korean news over the past 30 days are CG MedTech, Seers and Sky Labs.

Drtech KRX:214680KOSDAQ

디알텍 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked14since Sep 11

In Q2 2026, Drtech reported revenue of ₩37.0bn, up 10.3% year on year, and operating profit of ₩1.9bn. Drtech (디알텍) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 19 with 14 articles. The most common catalyst was clinical & approvals (14).

Drtech quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩37.0bn	+10.3%	₩1.9bn margin 5.0%	₩2.1bn
Q1 2026	₩31.8bn	+25.5%	−₩596m margin −1.9%	−₩885m
Q4 2025 derived	₩23.3bn	-14.6%	−₩13.0bn margin −55.5%	−₩16.6bn
Q3 2025	₩34.0bn	+27.9%	₩1.7bn margin 4.9%	₩2.8bn
Q2 2025	₩33.6bn	+27.4%	₩922m margin 2.7%	−₩5.9bn
Q1 2025	₩25.4bn	+46.8%	−₩3.5bn margin −13.9%	−₩4.4bn
Q4 2024 derived	₩27.3bn	+18.4%	−₩2.2bn margin −8.1%	−₩5.1bn
Q3 2024	₩26.6bn	+15.0%	−₩2.5bn margin −9.3%	−₩4.5bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Drtech top stories 2 weeks, by number of outlets

1
디알텍, 차세대 엑스레이 '뉴 엑시스 덱시' FDA 인증 획득
4 outlets · 5 articlesFirst report Oct 19 06:41 파이낸셜뉴스Regulatory approval
2
디알텍, 차세대 엑스레이 美 FDA 인증에 장중 ‘上’
3 outlets · 3 articlesFirst report Oct 19 09:35 조선비즈Regulatory approval
3
디알텍, 차세대 엑스레이 시스템 신제품 美 FDA 승인
2 outlets · 2 articlesFirst report Oct 19 08:31 머니투데이Regulatory approval
4
디알텍, 신형 엑스레이 제품 '美 FDA 인증' 소식에 급등
1 outlets · 1 articlesFirst report Oct 19 09:34 아이뉴스24Regulatory approval
5
디알텍, 엑스레이 시스템 美 FDA 인증…27%대 상승
1 outlets · 1 articlesFirst report Oct 19 09:52 아주경제Regulatory approval
6
디알텍, 디지털 엑스레이 시스템 美 FDA 인증에 급등
1 outlets · 1 articlesFirst report Oct 19 09:39 이코노뉴스Regulatory approval

Latest Drtech news Korean headlines

Oct 1914:01

Major디알텍, 엑스레이 FDA 510(k) 통과에 장중 상한가
비건뉴스Regulatory approval
Oct 1909:52

MajorFeatured디알텍, 엑스레이 시스템 美 FDA 인증…27%대 상승
아주경제Regulatory approval
Oct 1909:39

Major디알텍, 디지털 엑스레이 시스템 美 FDA 인증에 급등
이코노뉴스Regulatory approval
Oct 1909:35
MajorFeatured디알텍, 차세대 엑스레이 美 FDA 인증에 장중 ‘上’
조선비즈Regulatory approval
2 more on this story · 2 outlets
- 디알텍, 차세대 엑스레이 美 FDA 인증에 장중 ‘上’조선일보 · Oct 19 09:40
- 디알텍, 차세대 디지털 엑스레이 美 FDA 인증 획득에 장중 '상한가'와이드경제 · Oct 19 11:24
Oct 1909:34

MajorFeatured디알텍, 신형 엑스레이 제품 '美 FDA 인증' 소식에 급등
아이뉴스24Regulatory approval
Oct 1908:31
Major디알텍, 차세대 엑스레이 시스템 신제품 美 FDA 승인
머니투데이Regulatory approval
1 more on this story · 1 outlets
- 디알텍, 엑스레이 시스템 美 FDA 인증에 '上'뉴시스경제 · Oct 19 09:18
Oct 1906:41
Major디알텍, 차세대 엑스레이 '뉴 엑시스 덱시' FDA 인증 획득
파이낸셜뉴스Regulatory approval
4 more on this story · 3 outlets
- 디알텍, 신형 디지털 엑스레이 美 FDA 인증 획득이데일리 · Oct 19 09:13
- 디알텍, 신형 디지털 엑스레이 美 FDA 인증 획득이데일리 · Oct 19 09:14
- 디알텍, 차세대 엑스레이 신제품 美 FDA 인증 소식에 상한가한국경제 · Oct 19 09:18
- 디알텍, 엑스레이 시스템 FDA 인증 획득 소식에 '급등'컨슈머타임스 · Oct 19 09:38

Articles per day 2 weeks

1419

Company profile

CEO: 안성현
Industry: Medical devices
Founded: 2015-02-03
Fiscal year-end: December
Head office: 경기도 성남시
Website: drtech.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
CG MedTech	₩333m	82
Seers	₩12.9bn	76
Sky Labs	–	70
Medyssey	–	47
Classys	₩43.9bn	43
Won Tech	₩11.1bn	42
Dio	₩4.4bn	36
InBody	₩17.7bn	30

Compare Drtech side by side with these companies

Drtech DART filings

Sep 1017:30

Other 주식소각결정
Other
Sep 915:40

Trading halt / delisting 주권매매거래정지해제 (액면병합 주권 변경상장)
Risk & warnings

Catalysts 2 weeks

Clinical & approvals14

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Drtech FAQ

Who is the CEO of Drtech?: According to the DART company overview, Drtech's representative director is 안성현 (name as registered in Korean). The company was founded on 2015-02-03.
Where is Drtech listed?: Drtech trades on the Korea Exchange KOSDAQ market under the ticker 214680. Its fiscal year ends in December.
What were Drtech's latest quarterly results?: In Q2 2026, Drtech reported revenue of ₩37.0bn, up 10.3% year on year, and operating profit of ₩1.9bn. Figures come from reports filed on DART.
Does Drtech pay a dividend?: Drtech did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as Drtech?: Under the Korean Standard Industrial Classification recorded on DART, Drtech is grouped with 72 other listed companies in medical devices. The most covered in Korean news over the past 30 days are CG MedTech, Seers and Sky Labs.